HealthBanks Biotech

What HealthBanks Biotech does

HealthBanks Biotech, Inc. is a privately held, US-based dual biobank founded in 2001 (US operations since 2008) that provides private cellular preservation services to two primary customer segments: expectant families banking newborn stem cells from umbilical cord blood and cord tissue, and health-conscious adults banking peripheral blood mononuclear cells (PBMCs) for future immunotherapies such as CAR-T cell therapy. The company operates an on-site AABB-accredited, FDA-registered, CAP-accredited, CLIA-certified processing laboratory at its Rancho Cordova, California headquarters (relocated from Irvine in 2025), and is licensed by both the California Department of Public Health and the New York Department of Public Health.

Core products include Cord Blood Banking (collection kit, AXP II processing, BioArchive cryogenic storage), Cord Tissue Banking (Silver package — segmented tissue; Gold package — isolated mesenchymal stem cells expanded from Wharton Jelly), and Adult Immune Cell Banking (blood draw through partner centers, PXP closed-loop processing, BioArchive storage). The technology stack is differentiated by automated, FDA-approved processing systems manufactured by affiliated ThermoGenesis — the AXP II achieves 97%+ mononuclear cell recovery, the PXP achieves >99% MNC recovery and >99% RBC depletion, and the BioArchive provides robotic liquid-nitrogen storage at -196°C, claimed to deliver up to 94% post-thaw viability. All services are backed by a $50,000 engraftment guarantee.

The business model combines one-time processing and enrollment fees with recurring annual storage subscriptions ($200/year for cord blood) at published entry pricing of $19.99/month. Distribution is direct-to-consumer via phone and online enrollment, supplemented by healthcare provider referrals (obstetricians, midwives, hospitals), an embedded hospital collection network, and a self-reinforcing $150-per-referral affiliate program. The company is led by Dr. Chris Xu (Chairman and President) and Phil Coelho (CTO, co-founder of ThermoGenesis), and operates a joint venture — ImmuneCyte Life Sciences — with ThermoGenesis Holdings for cell therapy development.

Name

HealthBanks Biotech

Legal name

HealthBanks Biotech, Inc.

Website

https://healthbanks.us

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

HealthBanks Biotech is a US-based dual biobank founded in 2001 that provides private cord blood, cord tissue, mesenchymal stem cell, and adult immune cell banking services using FDA-approved automated processing and robotic cryogenic storage to expectant families and health-conscious adults.

Ownership category

akta.pro rank

Product category

Stem Cell & Immune Cell Banking Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Health Services (8000)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industry

Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

• Cord blood banking
• Immune cell banking
• Stem cell storage
• Cryogenic cell storage
• Mesenchymal stem cells

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Cord Blood Banking Services: One-time enrollment and processing fees plus recurring annual storage fees. First year includes collection kit, processing with AXP system, and first year of BioArchive storage. Subsequent years at $200/year.
2. Immune Cell Banking Services: Blood collection, processing with PXP system, and cryogenic storage for adult immune cells. Subscription-based annual storage model.
3. MSC Cord Tissue Processing: Advanced mesenchymal stem cell processing from cord tissue with cell expansion and cryopreservation services. Premium tier service with Gold package offering.
4. Referral Program: Customers receive $150 Visa Gift Card for referring friends; referred friends receive free first year of storage ($175 value).

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

HealthBanks Biotech is a dual biobank that collects, processes, and cryogenically stores newborn stem cells (cord blood and cord tissue, including isolated mesenchymal stem cells from Wharton's Jelly) and adult immune cells (peripheral blood mononuclear cells) for potential future therapeutic use. Services use FDA-cleared automated AXP II and PXP processing systems and the BioArchive robotic cryogenic vault, with samples stored at -196°C under a $50,000 engraftment guarantee.

Product overview

HealthBanks Biotech is a dual biobank offering both newborn stem cell and adult immune cell banking services. The core offerings include Cord Blood Banking (collecting and storing hematopoietic stem cells from umbilical cord blood) and Immune Cell Banking (preserving adult peripheral blood mononuclear cells). Supporting these are advanced processing technologies: the AXP® II system for cord blood processing and PXP® system for immune cell processing. Storage is provided via the BioArchive® automated cryogenic system. Additional services include Cord Tissue Banking (Silver package for segmented tissue and Gold package for isolated Mesenchymal Stem Cells from Wharton’s Jelly). All services are backed by a $50,000 engraftment guarantee.

Differentiator

Problem solved

Functional benefit

Brands

• PacifiCord: Sister brand mentioned in client testimonials alongside HealthBanks for cord blood banking services

Products and services

• Cord Blood Banking Private cord blood banking service that collects, processes with the AXP II automated system, and cryogenically stores hematopoietic stem cells (HSCs) from newborn umbilical cord blood for potential future treatment of cancers, metabolic disorders, immune, and blood-related diseases. Targeted at expectant US families, with kit provided for use at delivery.
• Cord Tissue Banking (Silver Package - Segmented Cord Tissue) Segmented cord tissue storage service in which umbilical cord tissue is cut into small pieces, mixed with cryoprotectant solution, and preserved for potential future therapeutic use. Packaged as the Silver tier offering.
• Isolated Mesenchymal Stem Cells from Cord Tissue (Gold Package) Advanced MSC processing service that isolates Mesenchymal Stem Cells from Wharton's Jelly of umbilical cord tissue, expands them in culture to grow in large numbers, and then cryopreserves them; positioned as offering 8x better cell viability than frozen tissue. Packaged as the Gold tier offering.
• Immune Cell Banking (Adult PBMC Storage) Adult immune cell banking service that collects a 150-200mL peripheral blood draw, processes the sample with the automated PXP system, and cryogenically stores peripheral blood mononuclear cells (PBMCs) at -196°C for future use in immunotherapies such as CAR-T cell therapy. Targeted at health-conscious US adults.
• Cord Blood Collection Kit FDA-approved sterile (Heparin-free) collection kit containing a collection bag with Citrate Phosphate Dextrose Solution (CPD) anticoagulant, used by clinicians at the hospital to collect cord blood during vaginal and cesarean section deliveries as part of HealthBanks' cord blood banking service.

Quantifiable outcome

• 97%+ viable CD34+ stem cell recovery rate with BioArchive system
• +4 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• ThermoGenesiscoreTechnology or Integration · 1 January 2020ThermoGenesis manufactures AXP, PXP, and BioArchive systems used by HealthBanks. They are an FDA-certified medical device manufacturer and affiliate company. HealthBanks uses their automated processing and cryogenic storage technology exclusively.
• Be The Match RegistrycoreStrategic or Co-development PartnerHealthBanks Group is a member of the Be The Match Registry, allowing families who haven't saved stem cells to find HLA-matches for transplant or cell therapy.
• University of Kansas Medical CenterminorStrategic or Co-development PartnerResearch partnership to develop a vaccine for HIV using cell therapy approaches.
• Taiwan Industrial Technology Research InstituteminorStrategic or Co-development PartnerResearch partnership for neurodegeneration treatment including Parkinson's, Alzheimer's, multiple sclerosis, and ALS.
• Johns Hopkins UniversityminorStrategic or Co-development PartnerResearch partnership with Johns Hopkins University and Taiwan University for HPV vaccine development for cervical cancer treatment and applications for HIV, Hepatitis B, Hepatitis C, and Avian influenza.
• UCLAminorStrategic or Co-development PartnerResearch partnership for cell expansion technology and treatments for spinal cord injuries.
• National Taiwan UniversityminorStrategic or Co-development PartnerPartnership for cell expansion research and treatments for diseases, disorders, and injuries.
• Taipei Medical UniversityminorStrategic or Co-development PartnerResearch collaboration for cell expansion and treatment research.
• Cell Stem Biotech Inc.minorStrategic or Co-development PartnerResearch project to develop cell expansion technology of cord blood hematopoietic stem cells for clinical transplant use.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Viacord: Established private cord blood banking service now part of PerkinElmer. Direct competitor targeting the same expectant family segment with comparable collection, processing, and annual storage offerings.
• StemCyte: Hybrid public/private cord blood bank with both family storage and a public inventory. Direct competitor in cord blood banking with similar AABB accreditation and HLA matching capabilities for transplant.
• Cryo-Cell International: Public US cord blood bank offering private and public storage plus menstrual stem cell banking. Most direct competitor in the dual bank positioning, with overlapping regulatory credentials (AABB, FDA) and similar recurring revenue economics.
• Cord Blood Registry (CBR): One of the largest US private cord blood banks, owned by CooperCompanies. Direct competitor in the cord blood and cord tissue banking category with overlapping customer segments (expectant families) and similar subscription-based storage model.
• Americord Registry: Private US cord blood and cord tissue bank serving expectant families. Direct competitor in cord blood banking with similar processing technology (also uses AXP) and storage subscription model.

Regional players

• Cells4Life: UK-based private cord blood and tissue bank. Operates a similar dual banking model (cord blood + cord tissue) with comparable subscription storage pricing, but primarily serves UK and European markets rather than the US.
• Future Health Biobank: UK and European private stem cell bank offering cord blood, cord tissue, and dental pulp storage. Similar service breadth to HealthBanks but geographically focused on European customers.

Emerging players

• CellectCell: Emerging adult immune cell banking service. Direct overlap with HealthBanks' immune cell banking business line, focused on preserving T-cells and NK cells for future cancer immunotherapy use.
• Acorn Biolabs: Canadian adult cell banking company focused on preserving stem cells from hair follicles for regenerative and cosmetic applications. Emerging player in the adult cell banking space with comparable D2C subscription model.

Others

• ThermoGenesis Holdings: Medical device manufacturer and HealthBanks affiliate that produces the AXP, PXP, and BioArchive systems. Sister company and exclusive technology supplier — not a direct competitor but a key strategic ecosystem participant whose commercial decisions directly shape HealthBanks' capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCp4IJO5C6fbH8yvtdMYD8Sw
• Facebookfacebook.com/healthbanks.us
• LinkedInlinkedin.com/company/healthbanks-us
• Instagraminstagram.com/healthbanks.us

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthBanks Biotech